TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

Home・Список акций・Genpact Ltd

Genpact Ltd

Закрыт

СекторТехнологии

34.08 -0.18

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

33.12

Макс.

34.14

Ключевые показатели
By Trading Economics
Доход	-2.7M 143M
Продажи	28M 1.3B
P/E Средняя по отрасли	10.978 86.001
Дивидендная доходность	1.98
Рентабельность продаж	10.846
Сотрудники	146,500
EBITDA	-29M 201M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+33.57% upside

Дивиденды
By Dow Jones
Дивидендная доходность Средняя по отрасли	1.98% 2.73%

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-1.9B 5.8B
Предыдущая цена открытия	34.26
Предыдущая цена закрытия	34.08

Новостные настроения

By Acuity

50%

162 / 374 Рейтинг в Technology

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

4.95 / N/A Поддержка и Сопротивление

Genpact Ltd График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

12 мар. 2026 г., 11:32 UTC

Отчет

Italian Insurer Generali Posts Rise in Profit -- Update

12 мар. 2026 г., 11:20 UTC

Отчет

Correction to Generali Flash Headlines

12 мар. 2026 г., 06:29 UTC

Отчет

Italian Insurer Generali Posts Rise in Profit on Growth Across Segments

15 апр. 2026 г., 06:09 UTC

Обсуждения рынка

Приобретения, слияния, поглощения

Generali Could Consider Capital-Light M&A to Grow Franchise, Deputy CEO Says -- Market Talk

12 мар. 2026 г., 08:27 UTC

Обсуждения рынка

Generali's AI Disclosure Is Pleasing -- Market Talk

12 мар. 2026 г., 07:01 UTC

Обсуждения рынка

Отчет

Generali's Beat Should Get Positive Share Reaction -- Market Talk

12 мар. 2026 г., 06:04 UTC

Отчет

Generali Backs 2027 View

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Life PVNBP EUR55.55B

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Life PVNBP EUR56.03B

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Life New Business Value EUR3.05B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Life New Business Value EUR3.15B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali End-2025 Solvency Ratio 219%

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali End-2025 Solvency Ratio 212%

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Undiscounted Combined Ratio 94.2%

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Combined Ratio 92.5%

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Combined Ratio 92.6%

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Undiscounted Combined Ratio 94.3%

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Dividend EUR1.59

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Adj. Net Pft EUR4.31B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali Declares Dividend of EUR1.64

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Adj. Net Pft EUR4.315B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali Announces EUR500M Buyback for 2026

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Net Inflows EUR16B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali End-2025 Assets Under Management EUR899.93B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Net Pft EUR4.17B

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Oper Result EUR7.965B

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Net Pft EUR4.225B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Life Written Premiums EUR61.94B

12 мар. 2026 г., 06:04 UTC

Отчет

Analysts Saw Generali 2025 Life Written Premiums EUR62.795B

12 мар. 2026 г., 06:04 UTC

Отчет

Generali 2025 Gross Written Premiums EUR98.12B

Сравнение c конкурентами

Изменение цены

Genpact Ltd Прогноз

Целевая цена

By TipRanks

33.57% рост

Прогноз на 12 месяцев

Средняя 45.6 USD 33.57%

Максимум 55 USD

Минимум 37 USD

Основано на мнении 5 аналитиков Wall Street, спрогнозировавших целевые цены для Genpact Ltd на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

5 ratings

Покупка

Удержание

Продажа

Основано на мнении 5 аналитиков, присваивавших рейтинги акциям Genpact Ltd – Данные за последние 3 месяца.

Техническая оценка

By Trading Central

4.95 / N/AПоддержка и Сопротивление

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Настроения

By Acuity

162 / 374Рейтинг в Технологии

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.